Health's weekend read includes kidney donations, cancer prevention, measles vaccinations and more [FOX News]
Lucid Diagnostics Inc. (LUCD)
Company Research
Source: FOX News
close Fox News Digital publishes an array of health pieces all week long to keep you in the know on a range of wellness topics: disease prevention, nutrition, medical research, health care and much more — plus, personal stories of people and families overcoming huge obstacles. This weekend, check out some of the top stories of the week in Health that you may have missed, or have been meaning to check out. These are just a few of what's new, of course. Many more can be seen at http://www.foxnews/health Check out this selection! Two hard-to-match transplant patients 250 miles apart started the year of 2024 with shining new hope for long, healthy lives — thanks to the collaboration of two Texas hospitals. The donors, recipients and doctors shared the events leading up to their surgeries. Click here to get the story. Lucid Diagnostics, a New York-based biotech company, created a vitamin-sized diagnostic to help prevent esophageal cancer. Fox News Digital spoke with Lishan A
Show less
Read more
Impact Snapshot
Event Time:
LUCD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUCD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUCD alerts
High impacting Lucid Diagnostics Inc. news events
Weekly update
A roundup of the hottest topics
LUCD
News
- Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024PR Newswire
- Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing [Yahoo! Finance]Yahoo! Finance
- Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingPR Newswire
- Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthPR Newswire
- Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.50 price target on the stock.MarketBeat
LUCD
Sec Filings
- 5/2/24 - Form 8-K
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form ARS
- LUCD's page on the SEC website